GoodRx Holdings Inc.
GDRX-
GoodRx Holdings Inc decreased 5.1% to $4.45 after the company reported quarterly results that were ahead of market's expectations but the online pharmacy estimated weaker-than-expected second quarter and full-year results.
Revenue declined to $183.9 million from $203.3 million and the company swung to a net loss of $3.3 million from a profit of $12.3 million and diluted earnings per share was ($0.01) compared to 3 cents a year ago.
Net loss in the quarter was impacted by $25.5 million of stock-based compensation expense, $6.9 million of which related to the non-recurring awards granted to co-founders in connection with the company's initial public offering.
As of the end of March, GoodRx had cash and cash equivalents of $761.1 million and total outstanding debt of $665.3 million.
May 10, 2023 -
GoodRx Holdings said revenue in the fourth quarter declined to $184 million from $213 million and net loss shrank to $1.9 million from $39.9 million and diluted earnings per share was breakeven compared to a loss of 10 cents from a year ago.
In 2022, revenue increased to $766.5 million from $745.4 million and net loss rose to $32.8 million from $25.2 million and diluted loss per share rose to 8 cents from 6 cents in the previous year.
Mar 1, 2023
|
|
| |
|
| Trading Volume | 67,355 |
|
|
9.06 - 4.44 |
| Market Cap Full | $ 3.4B |
Quarterly +
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Q1 | -56.7% | -4.8% | 6.1% | 34.1% |
| Q2 | - | 88% | 8.2% | -11.7% |
| Q3 | - | 88% | -9.4% | 2% |
| Q4 | - | 88% | -7% | 20.1% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2026 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | |||||||||||
| -4.8 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -10.5 | 29.8 | -8.7 | -5.8 | 17.6 | -2.2 | 17.7 | -9.4 | - | - | - | -3.4 |
| 2023 | |||||||||||
| 20 | -5.4 | 18.2 | -25.3 | 16.3 | 1.7 | 67.4 | -29.3 | -13.8 | -12.4 | 21.5 | 11.9 |
| 2022 | |||||||||||
| -26.5 | 14.1 | -29.5 | -27.5 | -43.2 | -25.7 | 5.2 | -2.1 | -23.4 | 15 | -18.8 | 6.9 |
| 2021 | |||||||||||
| 13.4 | -4.5 | -12.4 | 2.5 | -7.3 | -3 | -10.9 | 18.6 | 7.9 | 8.7 | -10.5 | -18.1 |
EPS
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Q1 | -0 | 0 | 0 |
| Q2 | 0.1 | 0 | 0.1 |
| Q3 | -0.1 | -0.1 | -0 |
| Q4 | 0 | -0 | -0.1 |
| A | 0.04 | -0.1 | -0.1 |